Literature DB >> 11209473

[Vaccination with allergens in children].

P Demoly1, H Dhivert-Donnadieu, J Bousquet.   

Abstract

Specific immunotherapy or allergen vaccination has been in routine use since 1911 for the treatment of respiratory allergic diseases. It is more effective in children and young adults than later in life. Its efficacy has been demonstrated in double-blind placebo controlled studies in both allergic rhinoconjunctivitis and allergic asthma. The improvement of allergenic extracts (in particular by standardization), the better understanding of the mechanisms of action of immunotherapy, the use of local administration routes and the publication of guidelines have legitimate its definite role to play in the therapeutic management of allergic respiratory diseases in childhood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11209473

Source DB:  PubMed          Journal:  Allerg Immunol (Paris)        ISSN: 0397-9148


  2 in total

1.  Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis.

Authors:  Edmir Américo Lourenço; Eduardo José Caldeira; César Alexandre Fabrega Carvalho; Marcelo Rodriques Cunha; Marcus Vinícius Henriques Carvalho; Saulo Duarte Passos
Journal:  Int Arch Otorhinolaryngol       Date:  2015-10-07

2.  Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies.

Authors:  Sara Zahmati; Morteza Taghizadeh; Setareh Haghighat; Reza Jalalirad; Mehdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.